BioNxt Solutions Inc
F:BXT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
BioNxt Solutions Inc
F:BXT
|
CA |
|
P
|
Prinsiri PCL
SET:PRIN
|
TH |
|
D
|
Doosan Skoda Power as
PSE:DSPW
|
CZ |
|
B
|
Bang & Olufsen A/S
XMUN:BUOB
|
DK |
|
O
|
Ocado Group PLC
F:0OC
|
UK |
|
Alamo Group Inc
NYSE:ALG
|
US |
|
B
|
Bank Pan Indonesia Tbk PT
XMUN:PTQ
|
ID |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
M
|
Mclaren Resources Inc
F:3ML
|
CA |
|
V
|
Vimi Fasteners SpA
MIL:VIM
|
IT |
|
Juventus FC SpA
F:JUV
|
IT |
|
H
|
HanTech Ltd
KOSDAQ:098070
|
KR |
|
Thomson Medical Group Ltd
F:3H5
|
SG |
|
P
|
Piaggio & C SpA
XMUN:P1I
|
IT |
|
Luxxfolio Holdings Inc
F:LUH0
|
CA |
|
A
|
Adtran Networks SE
XMUN:ADV
|
DE |
|
Innate Pharma SA
PAR:IPH
|
FR |
|
Secom Co Ltd
F:XSC
|
JP |
|
P
|
Prospect Logistics and Industrial Freehold and Leasehold Real Estate Investment Trust
SET:PROSPECT
|
TH |
|
Innate Pharma SA
F:IDDA
|
FR |
Bankruptcy Probability
BioNxt Solutions Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
BioNxt Solutions Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
B
|
BioNxt Solutions Inc
CNSX:BNXT
|
40.8m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
598.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
352.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
350.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
226.8B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
190.8B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
317.7B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
161.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CN |
|
BGM Group Ltd
NASDAQ:BGM
|
126B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
BioNxt Solutions Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, BioNxt Solutions Inc has total debt of 4m CAD. This includes both short-term (0 CAD) and long-term (4m CAD) debt.
You can find a full breakdown on its Balance Sheet.